Perampanel efficacy and safety by gender: Subanalysis of phase III randomized clinical studies in subjects with partial seizures

Epilepsia

Volumn 56, Issue 7, 2015, Pages e90-e94

  Vazquez, Blanca ^a   Yang, Haichen ^b   Williams, Betsy ^b   Zhou, Sharon ^b   Laurenza, Antonio ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b EISAI INC   (United States)

Author keywords

Antiepileptic drug; Efficacy; Gender; Perampanel; Pharmacokinetics; Safety

Indexed keywords

PERAMPANEL; PYRIDONE DERIVATIVE;

ARTICLE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG CLEARANCE; DRUG EFFICACY; DRUG EXPOSURE; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; FOCAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL CLEARANCE; PHASE 3 CLINICAL TRIAL; POST HOC ANALYSIS; PRIORITY JOURNAL; SEX DIFFERENCE; ADULT; BLOOD; CHEMICALLY INDUCED; CLINICAL TRIAL; CONTROLLED STUDY; EPILEPSIES, PARTIAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; DIZZINESS; DOUBLE-BLIND METHOD; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; PYRIDONES; TREATMENT OUTCOME;

EID: 84936846600     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.13019     Document Type: Article

References (22)

1. Schmidt D,. Drug treatment of epilepsy: options and limitations. Epilepsy Behav 2009; 15: 56-65.
2. Elger CE, Schmidt D,. Modern management of epilepsy: a practical approach. Epilepsy Behav 2008; 12: 501-539.
3. Franconi F, Brunelleschi S, Steardo L, et al., Gender differences in drug responses. Pharmacol Res 2007; 55: 81-95.
4. French JA, Krauss GL, Biton V, et al., Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology 2012; 79: 589-596.
5. French JA, Krauss GL, Steinhoff BJ, et al., Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305. Epilepsia 2013; 54: 117-125.
6. Krauss GL, Serratosa JM, Villanueva V, et al., Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures. Neurology 2012; 78: 1408-1415.
7. Franco V, Crema F, Iudice A, et al., Novel treatment options for epilepsy: focus on perampanel. Pharmacol Res 2013; 70: 35-40.
8. Gidal BE, Ferry J, Majid O, et al., Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures. Epilepsia 2013; 54: 1490-1497.
9. Steinhoff BJ, Ben-Menachem E, Ryvlin P, et al., Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies. Epilepsia 2013; 54: 1481-1489.
10. Johannessen Landmark C, Patsalos PN,. Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Rev Neurother 2010; 10: 119-140.
11. Bockbrader HN, Burger P, Knapp L, et al., Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures. Epilepsia 2011; 52: 248-257.
12. Boyd RA, Türck D, Abel RB, et al., Effects of age and gender on single-dose pharmacokinetics of gabapentin. Epilepsia 1999; 40: 474-479.
13. Lyrica (pregabalin) prescribing information. New York, NY: Pfizer Inc; 2014.
14. ® (vigabatrin) prescribing information. Deerfield, IL: Lundbeck; 2013.
15. ® (gabapentin) prescribing information. New York, NY: Parke-Davis, Division of Pfizer Inc.; 2014.
16. Patsalos PN,. The clinical pharmacology profile of the new antiepileptic drug perampanel: a novel noncompetitive AMPA receptor antagonist. Epilepsia 2015; 56: 12-27. Epub ahead of print.
17. Morrell MJ,. The new antiepileptic drugs and women: efficacy, reproductive health, pregnancy, and fetal outcome. Epilepsia 1996; 37: S34-S44.
18. Crawford P,. Best practice guidelines for the management of women with epilepsy. Epilepsia 2005; 46 (Suppl. 9): 117-124.
19. Reddy DS,. Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives. Expert Rev Clin Pharmacol 2010; 3: 183-192.
20. Sabers A,. Pharmacokinetic interactions between contraceptives and antiepileptic drugs. Seizure 2008; 17: 141-144.
21. Williams D,. Antiepileptic drugs and contraception. US Pharm 2014; 39: 39-42.
22. FYCOMPA (perampanel) US prescribing information. Woodcliff Lake, NJ: Eisai Inc.; 2014.